1. Home
  2. CYTK vs SOUN Comparison

CYTK vs SOUN Comparison

Compare CYTK & SOUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • SOUN
  • Stock Information
  • Founded
  • CYTK 1997
  • SOUN 2005
  • Country
  • CYTK United States
  • SOUN United States
  • Employees
  • CYTK N/A
  • SOUN N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • SOUN EDP Services
  • Sector
  • CYTK Health Care
  • SOUN Technology
  • Exchange
  • CYTK Nasdaq
  • SOUN Nasdaq
  • Market Cap
  • CYTK 4.6B
  • SOUN 5.2B
  • IPO Year
  • CYTK 2004
  • SOUN N/A
  • Fundamental
  • Price
  • CYTK $49.76
  • SOUN $14.69
  • Analyst Decision
  • CYTK Buy
  • SOUN Buy
  • Analyst Count
  • CYTK 15
  • SOUN 7
  • Target Price
  • CYTK $75.57
  • SOUN $14.50
  • AVG Volume (30 Days)
  • CYTK 2.7M
  • SOUN 65.5M
  • Earning Date
  • CYTK 11-05-2025
  • SOUN 11-11-2025
  • Dividend Yield
  • CYTK N/A
  • SOUN N/A
  • EPS Growth
  • CYTK N/A
  • SOUN N/A
  • EPS
  • CYTK N/A
  • SOUN N/A
  • Revenue
  • CYTK $85,738,000.00
  • SOUN $131,449,000.00
  • Revenue This Year
  • CYTK $330.96
  • SOUN $100.34
  • Revenue Next Year
  • CYTK $73.41
  • SOUN $28.84
  • P/E Ratio
  • CYTK N/A
  • SOUN N/A
  • Revenue Growth
  • CYTK 2635.74
  • SOUN 136.97
  • 52 Week Low
  • CYTK $29.31
  • SOUN $4.45
  • 52 Week High
  • CYTK $59.39
  • SOUN $24.98
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 63.01
  • SOUN 57.96
  • Support Level
  • CYTK $49.22
  • SOUN $13.91
  • Resistance Level
  • CYTK $53.58
  • SOUN $15.21
  • Average True Range (ATR)
  • CYTK 2.54
  • SOUN 0.99
  • MACD
  • CYTK 0.29
  • SOUN 0.06
  • Stochastic Oscillator
  • CYTK 76.53
  • SOUN 77.11

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SOUN SoundHound AI Inc

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

Share on Social Networks: